Enhanced cellular radiation sensitivity of androgen-independent human prostate tumor cells by onconase

Anticancer Research

Volumn 20, Issue 2 A, 2000, Pages 1037-1040

  Lee, Intae ^a,b   Lee, Young H ^b   Mikulski, Stanislaw M ^c   Lee, Jihean ^b   Shogen, Kuslima ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Alfacell Corporation   (United States)

Author keywords

DU145 human prostate cancer cells; Onconase; Oxygen consumption; Radiation sensitization

Indexed keywords

ANDROGEN; RANPIRNASE; RIBONUCLEASE; UNCLASSIFIED DRUG;

AMPHIBIA; ANIMAL CELL; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; ELECTRODE; GLIOMA; HUMAN; HUMAN CELL; MALE; NONHUMAN; OOCYTE; OXYGEN CONSUMPTION; OXYGEN DIFFUSION; OXYGEN TENSION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE TUMOR; RADIOSENSITIVITY; RAT;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL DIVISION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; EGG PROTEINS; GLIOMA; HUMANS; MALE; OXYGEN CONSUMPTION; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; RATS; RIBONUCLEASES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034011064     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Lee I., Lee YH, Mikulski SM, Lee J, Covone K and Shogen K: Tumoricidal effects of onconase on various tumors. J Surg Oncol 73: (in press), 2000.
2. Secomb TW, Hsu R, Braun RD, Ross JR, Gross JF and Dewhirst MW: Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels. Adv Exp Med & Biol 454: 629-634, 1998.
3. Wu YN, Mikulski SM, Ardelt W, Rybak SM and Ypole RJ: A cytotoxic ribonuclease, study of the mechanism of onconase cytotoxicity. J Biol Chem 268: 10686-10693, 1993.
4. Scher HI. Mazumdar M and Kelly WK: Clinical trials in relapsed prostate cancer: Defining the target. JNCI 88: 1623-1634, 1996.
5. Raghavan D, Koczwara B and Javle M: Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. Eur J Cancer 33: 566-574, 1997.
6. Rhee JG, Lee I and Song CW: The clonogenic response of aortic endothelial cells in culture to radiation. Radiat Res 106: 182-189, 1986.
7. Biaglow JE, Lavik P and Ferencz N: Modification of radiation response through glucose-controlled respiration. Radiat Res 39: 623-633, 1969.
8. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB: Wild-type p53 is a cell-cycle checkpoint determinant following irradiation. Pro Natl Acad Sci USA 89: 7491-7495, 1992.
9. KIP and decreased pRb phosphorylation. Leukemia 12: 1241-1248, 1998.
10. Darynkiewicz Z, Carter SP, Mikulski SM, Ardelt WJ and Shogen K: Cytostatic and cytotoxic effects of Pannon (P-30 protein), a novel anticancer agent. Cell & Tissue Kinetics 21: 169-182, 1988.
11. Mosimann S, Johns K, Ardelt W, Mikulski SM, Shogen K and James M: Comparative molecular modeling and crystallization of P-30 protein: a novel antitumor protein of Rana pipiens oocytes and early embryos. Proteins: structure, function & genetics 14: 392-400, 1992.
12. Lee I, Glickson JD, Dewhirst MW, Leeper D, Burd R, Poptani H, Nadal L, McKenna WG and Biaglow JE: Effect of mild hyperglycemia ± meta-iodo-benzylguanidine on the radiation response of R3230 AC tumors. Submitted to the proceedings at the 27th International Society on Oxygen Transport to Tissue (ISOTT), Hanover, New Hampshire, 1999.